About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
EventsCardiawave will participate in the 2nd edition of the HIFUture symposium – Apr. 21 – Lyon Apr 20, 2023 READ MORE
EventsCardiawave will be presenting at the combined ISTU/EUFUS Symposium – Apr. 18 – Lyon Apr 18, 2023 READ MORE
Press ReleaseCardiawave lauréate de la première promotion French Tech Health20 Apr 14, 2023 READ MORE
EventsCardiawave présente à la 8ème édition de la « Journée start-up innovantes du dispositif médical » – Apr. 4 – Paris Apr 13, 2023 READ MORE
About UsCardiawave est lauréate de la première promotion du French Tech Health20 ! Mar 27, 2023 READ MORE
Clinical Studies2 patients treated last week in our new clinical study site OLVG! Mar 15, 2023 READ MORE
About Us CHU Rouen among the first centers in Europe to adopt Valvosoft® technology following its CE marking Jul 9, 2026 HeleneCardiawave 0
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
